2 active warrant series covering 10,074,000 shares (~4.8% potential dilution); nearest expiry 2028-03-13.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.06 | Mar 13, 2028 530d | 5.0M | OTM | 2.4% | C$322K | Auto |
| finder | $0.07 | Mar 13, 2028 530d | 5.0M | OTM | 2.4% | C$327K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 14,750,000 shares (~7.1% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.14 | May 14, 2028 592d | 14.8M | OTM | 7.1% | C$2.1M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
209,073,166 shares outstanding, plus 10,074,000 from warrants and 14,750,000 from options — a fully diluted 233,897,166 shares, or ~11.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
2 active warrant series covering 10,074,000 shares (~4.8% potential dilution); nearest expiry 2028-03-13.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.06 | Mar 13, 2028 530d | 5.0M | OTM | 2.4% | C$322K | Auto |
| finder | $0.07 | Mar 13, 2028 530d | 5.0M | OTM | 2.4% | C$327K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
1 option grant covering 14,750,000 shares (~7.1% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.14 | May 14, 2028 592d | 14.8M | OTM | 7.1% | C$2.1M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
209,073,166 shares outstanding, plus 10,074,000 from warrants and 14,750,000 from options — a fully diluted 233,897,166 shares, or ~11.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
